Innate immune checkpoint Siglec10 in cancers: mining of comprehensive omics data and validation in patient samples

C Zhang, J Zhang, F Liang, H Guo, S Gao, F Yang… - Frontiers of …, 2022 - Springer
Sialic acid binding Ig-like lectin 10 (Siglec10) is a member of innate immune checkpoints
that inhibits the activation of immune cells through the interaction with its ligand CD24 on …

Insights into the role of sialylation in cancer metastasis, immunity, and therapeutic opportunity

J Huang, J Huang, G Zhang - Cancers, 2022 - mdpi.com
Simple Summary Sialylation is the synthetic process of sialoglycans, which are important in
tumor transformation, proliferation, metastasis, and immune evasion. The primary subjects of …

Normalization cancer immunotherapy: blocking Siglec-15!

G Cao, Z Xiao, Z Yin - Signal transduction and targeted therapy, 2019 - nature.com
Cancer cells can develop various mechanisms to evade tumorspecific and non-specific
attacks in the TME of solid tumors. 2 Thus, systemic activation of immune systems or even …

A sulfonamide sialoside analogue for targeting Siglec-8 and-F on immune cells

CM Nycholat, S Duan, E Knuplez, C Worth… - Journal of the …, 2019 - ACS Publications
The Siglec family of cell surface receptors have emerged as attractive targets for cell-
directed therapies due to their restricted expression on immune cells, endocytic properties …

Targeting siglecs—a novel pharmacological strategy for immuno-and glycotherapy

C Jandus, HU Simon, S von Gunten - Biochemical pharmacology, 2011 - Elsevier
The immune system must be tightly held in check to avoid bystander tissue damage as well
as autoreactivity caused by overwhelming immune reactions. A novel family of …

Disruption of sialic acid metabolism drives tumor growth by augmenting CD8+ T cell apoptosis

LAM Cornelissen, A Blanas… - … journal of cancer, 2019 - Wiley Online Library
Sialylated glycan structures are known for their immunomodulatory capacities and their
contribution to tumor immune evasion. However, the role of aberrant sialylation in colorectal …

Attenuation of sialylation augments antitumor immunity and improves response to immunotherapy in ovarian cancer

K Cao, G Zhang, M Yang, Y Wang, M He, C Zhang… - Cancer research, 2023 - AACR
Aberrant sialylation functions as an important modulator of all steps of malignant
transformation. Therefore, targeting sialylation regulators, such as sialyltransferases and …

Siglec‐1 and‐2 as potential biomarkers in autoimmune disease

AJ Eakin, MJ Bustard, CM McGeough… - PROTEOMICS …, 2016 - Wiley Online Library
Autoimmune diseases (ADs) are currently treated with anti‐inflammatory and
immunosuppressive drugs, aimed at reducing symptoms of disease in order to improve …

Siglecs in brain function and neurological disorders

SS Siddiqui, R Matar, M Merheb, R Hodeify… - Cells, 2019 - mdpi.com
Siglecs (Sialic acid-binding immunoglobulin-type lectins) are a I-type lectin that typically
binds sialic acid. Siglecs are predominantly expressed in immune cells and generate …

The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF-β secretion from monocytes/macrophages through the DAP12–Syk pathway

R Takamiya, K Ohtsubo, S Takamatsu… - …, 2013 - academic.oup.com
We previously demonstrated that Siglec-15, a member of the Siglec family of glycan-
recognition proteins, is expressed on a subset of macrophages and preferentially …